SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-049239
Filing Date
2024-04-26
Accepted
2024-04-26 16:40:07
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A inzy_2024_defa14a.htm DEFA14A 28316
2 GRAPHIC img30583070_0.jpg GRAPHIC 1374424
3 GRAPHIC img30583070_1.jpg GRAPHIC 112909
  Complete submission text file 0000950170-24-049239.txt   2076317
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39397 | Film No.: 24884587
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)